Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Cosmos Health Inc. (COSM)
|
Add to portfolio |
|
|
|
| Price: |
$3.59
| | Metrics |
| OS: |
10.6
|
M
| |
|
|
| Market cap: |
$38.1
|
M
| |
|
|
|
|
|
| |
|
|
|
|
|
| | | |
| | | | | |
| TTM Valuation | | | |
|
|
|
| |
|
|
|
|
|
| |
|
|
| EPS |
| |
|
|
|
BVPS
|
$4.15
| |
0.87
|
x P/B
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Mar-31-22 | Dec-31-21 | Mar-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 |
| Revenues | 13.1 | 56.2 | 11.6 | 55.4 | 39.7 | 37.1 | 30.0 | 6.8 |
| Revenue growth | 12.5% | 1.5% | | 39.6% | 7.0% | 23.6% | 344.3% | 1165.5% |
| Cost of goods sold | 11.2 | 50.4 | 10.6 | 49.4 | 36.0 | 34.7 | 28.1 | 6.2 |
| Gross profit | 1.9 | 5.9 | 1.0 | 6.0 | 3.7 | 2.4 | 2.0 | 0.6 |
| Gross margin | 14.5% | 10.4% | 8.6% | 10.8% | 9.2% | 6.5% | 6.5% | 8.9% |
| Selling, general and administrative | -11.2 | | -10.6 | | | | | |
| Sales and marketing | | 0.7 | | 0.8 | 0.2 | | | |
| General and administrative | | 9.2 | | 4.2 | 3.3 | 3.6 | 4.9 | 0.8 |
| EBITA | 0.2 | -4.5 | -1.7 | 2.7 | -0.2 | -1.4 | -2.9 | -0.2 |
| EBITA margin | 1.9% | -8.0% | -14.9% | 5.0% | -0.6% | -3.7% | -9.7% | -3.0% |
| Amortization of intangibles | | 0.0 | | 0.0 | 0.0 | 0.0 | 0.0 | |
| EBIT | 0.2 | -4.5 | -1.7 | 2.7 | -0.3 | -1.4 | -2.9 | -0.2 |
| EBIT margin | 1.9% | -8.1% | -14.9% | 4.9% | -0.6% | -3.7% | -9.7% | -3.0% |
| Pre-tax income | 0.0 | -7.8 | 0.0 | 1.2 | -3.1 | -9.0 | -6.2 | -0.6 |
| Income taxes | 0.0 | 0.1 | 0.0 | 0.4 | 0.2 | 0.0 | 0.0 | 0.0 |
| Tax rate | | | | 31.5% | | | | |
| Net income | 0.2 | -15.6 | -2.2 | 0.8 | -3.3 | -9.1 | -6.2 | -0.6 |
| Net margin | 1.6% | -27.7% | -18.7% | 1.5% | -8.3% | -24.4% | -20.7% | -8.9% |
| |
| Diluted EPS | | ($0.95) | | $0.06 | ($0.25) | ($0.68) | ($0.49) | ($0.05) |
| Shares outstanding (diluted) | | 16.4 | | 13.3 | 13.3 | 13.3 | 12.8 | 12.6 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|